SE164063C1 - - Google Patents

Info

Publication number
SE164063C1
SE164063C1 SE164063DA SE164063C1 SE 164063 C1 SE164063 C1 SE 164063C1 SE 164063D A SE164063D A SE 164063DA SE 164063 C1 SE164063 C1 SE 164063C1
Authority
SE
Sweden
Application number
Publication date
Publication of SE164063C1 publication Critical patent/SE164063C1/xx

Links

SE164063D SE164063C1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE164063T

Publications (1)

Publication Number Publication Date
SE164063C1 true SE164063C1 (en:Method) 1958-07-22

Family

ID=41955299

Family Applications (1)

Application Number Title Priority Date Filing Date
SE164063D SE164063C1 (en:Method)

Country Status (1)

Country Link
SE (1) SE164063C1 (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302465A (en) 1979-07-10 1981-11-24 Thuresson Af Ekenstam Bo Therapeutically active, substituted piperidines and pyrrolidines therapeutic compositions thereof and methods of use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302465A (en) 1979-07-10 1981-11-24 Thuresson Af Ekenstam Bo Therapeutically active, substituted piperidines and pyrrolidines therapeutic compositions thereof and methods of use thereof

Similar Documents

Publication Publication Date Title
IT605163A (en:Method)
FR536M (en:Method)
AT221043B (en:Method)
DE1071521C2 (en:Method)
AT217439B (en:Method)
FI43062B (en:Method)
JPS347814B1 (en:Method)
AT214270B (en:Method)
AT219815B (en:Method)
AT217982B (en:Method)
AT216831B (en:Method)
AT219868B (en:Method)
AT216803B (en:Method)
AT216771B (en:Method)
AT213670B (en:Method)
LU35790A1 (en:Method)
BE563683A (en:Method)
BE583944A (en:Method)
BE575926A (en:Method)
BE575898A (en:Method)
BE575276A (en:Method)
BE575045A (en:Method)
BE567892A (en:Method)
BE567393A (en:Method)
BE555601A (en:Method)